Current approaches for diagnosis of subclinical pulmonary tuberculosis, clinical implications and future perspectives: a scoping review

References

• Drain PK, Bajema KL, Dowdy D, et al. Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection. Clin Microbiol Rev. 2018 Oct;31(4). doi: 10.1128/CMR.00021-18
   PubMed Web of Science ®Google Scholar
• Kendall EA, Shrestha S, Dowdy DW. The epidemiological importance of subclinical tuberculosis. A critical reappraisal. Am J Respir Crit Care Med. 2021;203(2):168–174.
   PubMed Web of Science ®Google Scholar
• Migliori GB, Ong CWM, Petrone L, et al. The definition of tuberculosis infection based on the spectrum of tuberculosis disease. Breathe (Sheff). 2021 Sep;17(3):210079.
   PubMedGoogle Scholar
• Wong EB. It is time to focus on asymptomatic tuberculosis. Clin Infect Dis. 2021;72(12):e1044. doi: 10.1093/cid/ciaa1827
   PubMed Web of Science ®Google Scholar
• Mendelsohn SC, Fiore-Gartland A, Awany D, et al. Clinical predictors of pulmonary tuberculosis among South African adults with HIV. EClinicalMedicine. 2022 Mar;45:101328.
   PubMedGoogle Scholar
• Xu Y, Cancino-Muñoz I, Torres-Puente M, et al. High-resolution mapping of tuberculosis transmission: whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain. PLOS Med. 2019;16(10):e1002961. doi: 10.1371/journal.pmed.1002961
   PubMed Web of Science ®Google Scholar
• Emery JC, Dodd PJ, Banu S, et al. Estimating the contribution of subclinical tuberculosis disease to transmission: an individual patient data analysis from prevalence surveys. Elife. 2023 Dec 18;12:e82469. doi: 10.7554/eLife.82469
   Google Scholar
• Zaidi SMA, Coussens AK, Seddon JA, et al. Beyond latent and active tuberculosis: a scoping review of conceptual frameworks. EClinicalMedicine. 2023 Dec;66:102332. doi: 10.1016/j.eclinm.2023.102332
   PubMedGoogle Scholar
• World Health Organization. Global Tuberculosis Programme (GTB). Tuberculosis prevalence surveys: a handbook. World Health Organization; 2013.
   Google Scholar
• Frascella B, Richards AS, Sossen B, et al. Subclinical tuberculosis disease-a review and analysis of prevalence surveys to inform definitions, burden, associations, and screening methodology. Clin Infect Dis. 2021 Aug 2;73(3):e830–e841. doi: 10.1093/cid/ciaa1402
   PubMed Web of Science ®Google Scholar
• Onozaki I, Law I, Sismanidis C, et al. National tuberculosis prevalence surveys in Asia, 1990-2012: an overview of results and lessons learned. Trop Med Int Health. 2015 Sep;20(9):1128–1145.
   PubMed Web of Science ®Google Scholar
• Min J, Chung C, Jung SS, et al. Clinical profiles of subclinical disease among pulmonary tuberculosis patients: a prospective cohort study in South Korea. BMC Pulm Med. 2020;20(1):1–9. doi: 10.1186/s12890-020-01351-z
   PubMed Web of Science ®Google Scholar
• Liu E, Makubi A, Drain P, et al. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy. AIDS. 2015 Jul 17;29(11):1391–1399. doi: 10.1097/QAD.0000000000000705
   PubMed Web of Science ®Google Scholar
• Gunasekera K, Cohen T, Gao W, et al. Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey. Int J Tuberc Lung Dis. 2020;24(3):340–346. doi: 10.5588/ijtld.19.0387
   PubMed Web of Science ®Google Scholar
• Ellis PK, Martin WJ, Dodd PJ. CD4 count and tuberculosis risk in HIV-positive adults not on ART: a systematic review and meta-analysis. PeerJ. 2017;5:e4165. doi: 10.7717/peerj.4165
   PubMed Web of Science ®Google Scholar
• Kufa T, Mabuto T, Muchiri E, et al. Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysis. PLoS One. 2014;9(11):e111209. doi: 10.1371/journal.pone.0111209
   PubMed Web of Science ®Google Scholar
• Oni T, Burke R, Tsekela R, et al. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax. 2011;66(8):669–673. doi: 10.1136/thx.2011.160168
   PubMed Web of Science ®Google Scholar
• Riou C, Du Bruyn E, Stek C, et al. Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection. J Clin Investig. 2021;131(12). doi: 10.1172/JCI149125
   PubMed Web of Science ®Google Scholar
• Ledesma JR, Ma J, Zheng P, et al. Interferon-gamma release assay levels and risk of progression to active tuberculosis: a systematic review and dose-response meta-regression analysis. BMC Infect Dis. 2021 May 22;21(1):467. doi: 10.1186/s12879-021-06141-4
   PubMed Web of Science ®Google Scholar
• Singer SN, Ndumnego OC, Kim RS, et al. Plasma host protein biomarkers correlating with increasing mycobacterium tuberculosis infection activity prior to tuberculosis diagnosis in people living with HIV. EBioMedicine. 2022 Jan;75:103787.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li H, Song S, et al. Transmission of tuberculosis in an incarcerated population during the subclinical period: a cross-sectional study in Qingdao, China. Front Public Health. 2023;11:1098519. doi: 10.3389/fpubh.2023.1098519
   PubMed Web of Science ®Google Scholar
• Organization WH. Global tuberculosis report 2021: supplementary material. 2022.
   Google Scholar
• Bayaa R, Ndiaye MDB, Chedid C, et al. Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring. Sci Rep. 2021 Jul 1;11(1):13646. doi: 10.1038/s41598-021-93059-1
   PubMed Web of Science ®Google Scholar
• Roya-Pabon CL, Perez-Velez CM. Tuberculosis exposure, infection and disease in children: a systematic diagnostic approach. Pneumonia (Nathan). 2016;8(1):23. doi: 10.1186/s41479-016-0023-9
   PubMedGoogle Scholar
• Gill CM, Dolan L, Piggott LM, et al. New developments in tuberculosis diagnosis and treatment. Breathe (Sheff). 2022 Mar;18(1):210149.
   PubMedGoogle Scholar
• World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: xpert MTB. Policy update ed. World Health Organization; 2013.
   Google Scholar
• Nikam C, Jagannath M, Narayanan MM, et al. Rapid diagnosis of Mycobacterium tuberculosis with Truenat MTB: a near-care approach. PLoS One. 2013;8(1):e51121. doi: 10.1371/journal.pone.0051121
   PubMed Web of Science ®Google Scholar
• Cantera JL, Lillis LM, Peck RB, et al. Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis. PLoS One. 2022;17(9):e0274415. doi: 10.1371/journal.pone.0274415
   PubMed Web of Science ®Google Scholar
• Shapiro AE, Olson AM, Kidoguchi L, et al. Complementary nonsputum diagnostic testing for tuberculosis in people with HIV using oral swab PCR and urine lipoarabinomannan detection. J Clin Microbiol. 2022 Aug 17;60(8):e0043122. doi: 10.1128/jcm.00431-22
   PubMed Web of Science ®Google Scholar
• Shah M, Hanrahan C, Wang ZY, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults. Cochrane Database Syst Rev. 2016 May 10;2016(5):Cd011420. doi: 10.1002/14651858.CD011420.pub2
   PubMedGoogle Scholar
• Székely R, Sossen B, Mukoka M, et al. Multicentre accuracy trial of FUJIFILM SILVAMP TB LAM test in people with HIV reveals lot variability. medRxiv. 2022 Sep 9;22278961. doi: 10.1101/2022.09.07.22278961
   Google Scholar
• Yu G, Shen Y, Ye B, et al. Diagnostic accuracy of Mycobacterium tuberculosis cell-free DNA for tuberculosis: a systematic review and meta-analysis. PLoS One. 2021;16(6):e0253658. doi: 10.1371/journal.pone.0253658
   PubMed Web of Science ®Google Scholar
• Oreskovic A, Panpradist N, Marangu D, et al. Diagnosing pulmonary tuberculosis by using sequence-specific purification of urine cell-free DNA. J Clin Microbiol. 2021 Jul 19;59(8):e0007421. doi: 10.1128/JCM.00074-21
   PubMed Web of Science ®Google Scholar
• Keer JT, Birch L. Molecular methods for the assessment of bacterial viability. J Microbiol Methods. 2003 May;53(2):175–183. doi: 10.1016/S0167-7012(03)00025-3
   PubMed Web of Science ®Google Scholar
• Lu J, Zheng H, Chu P, et al. Direct detection from clinical sputum samples to differentiate live and dead Mycobacterium Tuberculosis. J Clin Lab Anal. 2019 Mar;33(3):e22716.
   PubMed Web of Science ®Google Scholar
• Barr DA, Omollo C, Mason M, et al. Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria. Sci Rep. 2021 Sep 20;11(1):18661. doi: 10.1038/s41598-021-98176-5
   PubMed Web of Science ®Google Scholar
• Babin BM, Fernandez-Cuervo G, Sheng J, et al. Chemiluminescent protease probe for rapid, sensitive, and inexpensive detection of live mycobacterium tuberculosis. ACS Cent Sci. 2021 May 26;7(5):803–814. doi: 10.1021/acscentsci.0c01345
   PubMed Web of Science ®Google Scholar
• Walter ND, Born SEM, Robertson GT, et al. Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens. Nat Commun. 2021 May 18;12(1):2899. doi: 10.1038/s41467-021-22833-6
   PubMed Web of Science ®Google Scholar
• Rogers GB, Stressmann FA, Koller G, et al. Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections. Diagn Microbiol Infect Dis. 2008 Oct;62(2):133–141.
   PubMed Web of Science ®Google Scholar
• Dorn-In S, Gareis M, Schwaiger K. Differentiation of live and dead mycobacterium tuberculosis complex in meat samples using PMA qPCR. Food Microbiol. 2019 Dec;84:103275. doi: 10.1016/j.fm.2019.103275
   PubMed Web of Science ®Google Scholar
• Nikolayevskyy V, Miotto P, Pimkina E, et al. Utility of propidium monoazide viability assay as a biomarker for a tuberculosis disease. Tuberculosis (Edinb). 2015 Mar;95(2):179–185.
   PubMed Web of Science ®Google Scholar
• Seiler P, Ulrichs T, Bandermann S, et al. Cell-wall alterations as an attribute of mycobacterium tuberculosis in latent infection. J Infect Dis. 2023 Nov 1;188(9):1326–1331. doi: 10.1086/378563
   PubMed Web of Science ®Google Scholar
• Alebouyeh S, Weinrick B, Achkar JM, et al. Feasibility of novel approaches to detect viable mycobacterium tuberculosis within the spectrum of the tuberculosis disease. Front Med. 2022;9:965359. doi: 10.3389/fmed.2022.965359
   Web of Science ®Google Scholar
• Heyckendorf J, Gillespie SH, Ruhwald M. Culture-free proof of mycobacterium tuberculosis - a new assay for viable bacteria. EBioMedicine. 2020 Dec;62:103117. doi: 10.1016/j.ebiom.2020.103117
   PubMed Web of Science ®Google Scholar
• Wang WH, Takeuchi R, Jain SH, et al. A novel, rapid (within hours) culture-free diagnostic method for detecting live mycobacterium tuberculosis with high sensitivity. EBioMedicine. 2020 Oct;60:103007.
   PubMed Web of Science ®Google Scholar
• Rauhut R, Klug G. mRNA degradation in bacteria. FEMS Microbiol Rev. 1999 Jun;23(3):353–370. doi: 10.1111/j.1574-6976.1999.tb00404.x
   PubMed Web of Science ®Google Scholar
• Weigel KM, Jones KL, Do JS, et al. Molecular viability testing of bacterial pathogens from a complex human sample matrix. PLoS One. 2013;8(1):e54886. doi: 10.1371/journal.pone.0054886
   PubMed Web of Science ®Google Scholar
• Cubero N, Esteban J, Palenque E, et al. Evaluation of the detection of mycobacterium tuberculosis with metabolic activity in culture-negative human clinical samples. Clin Microbiol Infect. 2013 Mar;19(3):273–278.
   PubMed Web of Science ®Google Scholar
• Kuehn MJ, Kesty NC. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 2005 Nov 15;19(22):2645–2655. doi: 10.1101/gad.1299905
   PubMed Web of Science ®Google Scholar
• Prados-Rosales R, Baena A, Martinez LR, et al. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest. 2011 Apr;121(4):1471–1483.
   PubMed Web of Science ®Google Scholar
• Schirmer S, Rauh L, Alebouyeh S, et al. Immunogenicity of mycobacterial extracellular vesicles isolated from host-related conditions informs about tuberculosis disease status. Front Microbiol. 2022;13:907296. doi: 10.3389/fmicb.2022.907296
   PubMed Web of Science ®Google Scholar
• Zheng W, LaCourse SM, Song B, et al. Diagnosis of paediatric tuberculosis by optically detecting two virulence factors on extracellular vesicles in blood samples. Nat Biomed Eng. 2022 Aug;6(8):979–991.
   PubMed Web of Science ®Google Scholar
• Kumar S, Gopinathan R, Chandra GK, et al. Rapid detection of bacterial infection and viability assessment with high specificity and sensitivity using raman microspectroscopy. Anal Bioanal Chem. 2020 Apr;412(11):2505–2516.
   PubMed Web of Science ®Google Scholar
• Mamishi S, Pourakbari B, Marjani M, et al. Diagnosis of latent tuberculosis infection among immunodeficient individuals: review of concordance between interferon-gamma release assays and the tuberculin skin test. Br J Biomed Sci. 2014;71(3):115–124. doi: 10.1080/09674845.2014.11669976
   PubMed Web of Science ®Google Scholar
• Pourakbari B, Mamishi S, Marjani M, et al. Novel T-cell assays for the discrimination of active and latent tuberculosis infection: the diagnostic value of PPE family. Mol Diagn Ther. 2015 Oct;19(5):309–316.
   PubMed Web of Science ®Google Scholar
• Pourakbari B, Mamishi S, Benvari S, et al. Comparison of the QuantiFERON-TB gold plus and QuantiFERON-TB gold in-tube interferon-γ release assays: a systematic review and meta-analysis. Adv Med Sci. 2019 Sep;64(2):437–443.
   PubMed Web of Science ®Google Scholar
• Rezaei N, Hosseini N-S, Saghazadeh A, et al. Tuberculosis: integrated studies for a complex disease 2050. Tuberculosis: integrated studies for a complex disease. Springer International Publishing; 2023. p. 1063–1098.
   Google Scholar
• Mahmoudi S, Pourakbari B, Mamishi S. Immunodiagnostics of tuberculosis: recent discoveries. Tuberculosis: integrated studies for a complex disease. Springer International Publishing; 2023. p. 139–150.
   Google Scholar
• Andrews JR, Nemes E, Tameris M, et al. Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study. Lancet Respir Med. 2017 Apr;5(4):282–290.
   PubMed Web of Science ®Google Scholar
• Li Q, Ren W, Yuan J, et al. Significant difference in Th1/Th2 paradigm induced by tuberculosis-specific antigens between IGRA-positive and IGRA-negative patients. Front Immunol. 2022;13:904308. doi: 10.3389/fimmu.2022.904308
   PubMed Web of Science ®Google Scholar
• Scriba TJ, Penn-Nicholson A, Shankar S, et al. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. PLOS Pathog. 2017 Nov;13(11):e1006687.
   PubMed Web of Science ®Google Scholar
• Delogu G, Chiacchio T, Vanini V, et al. Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders. PLoS One. 2011 Mar 29;6(3):e18315. doi: 10.1371/journal.pone.0018315
   PubMed Web of Science ®Google Scholar
• Chiacchio T, Delogu G, Vanini V, et al. Immune characterization of the HBHA-specific response in mycobacterium tuberculosis-infected patients with or without HIV infection. PLoS One. 2017;12(8):e0183846. doi: 10.1371/journal.pone.0183846
   PubMed Web of Science ®Google Scholar
• Tang J, Huang Y, Cai Z, et al. Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-γ release assay (IGRA) for discrimination of latent and active tuberculosis: a systematic review and meta-analysis. PLoS One. 2021;16(7):e0254571. doi: 10.1371/journal.pone.0254571
   PubMed Web of Science ®Google Scholar
• Mamishi S, Mahmoudi S, Banar M, et al. Diagnostic accuracy of interferon (IFN)-γ inducible protein 10 (IP-10) as a biomarker for the discrimination of active and latent tuberculosis. Mol Biol Rep. 2019 Dec;46(6):6263–6269.
   PubMed Web of Science ®Google Scholar
• Mamishi S, Pourakbari B, Sadeghi RH, et al. Diagnostic accuracy of monocyte chemotactic protein (MCP)-2 as biomarker in response to PE35/PPE68 proteins: a promising diagnostic method for the discrimination of active and latent tuberculosis. Protein Pept Lett. 2019;26(4):281–286. doi: 10.2174/0929866526666190119165805
   PubMed Web of Science ®Google Scholar
• Mamishi S, Pourakbari B, Shams H, et al. Improving T-cell assays for diagnosis of latent TB infection: confirmation of the potential role of testing interleukin-2 release in Iranian patients. Allergol Immunopathol (Madr). 2016 Jul;44(4):314–321
   PubMed Web of Science ®Google Scholar
• Mamishi S, Pourakbari B, Marjani M, et al. Discriminating between latent and active tuberculosis: the role of interleukin-2 as biomarker. J Infect. 2015 Apr;70(4):429–431.
   PubMed Web of Science ®Google Scholar
• Tanner R, O’Shea MK, Fletcher HA, et al. In vitro mycobacterial growth inhibition assays: a tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy. Vaccine. 2016 Sep 7;34(39):4656–4665. doi: 10.1016/j.vaccine.2016.07.058
   PubMed Web of Science ®Google Scholar
• O’Shea MK, Tanner R, Müller J, et al. Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection. Sci Rep. 2018 Sep 27;8(1):14480. doi: 10.1038/s41598-018-32755-x
   PubMedGoogle Scholar
• Lee H, Kim J, Kang YA, et al. In vitro mycobacterial growth inhibition in South Korean adults with latent TB infection. Front Immunol. 2019;10:896. doi: 10.3389/fimmu.2019.00896
   PubMed Web of Science ®Google Scholar
• Tabone O, Verma R, Singhania A, et al. Blood transcriptomics reveal the evolution and resolution of the immune response in tuberculosis. J Exp Med. 2021 Oct 4;218(10). doi: 10.1084/jem.20210915
   PubMed Web of Science ®Google Scholar
• Esmail H, Lai RP, Lesosky M, et al. Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis. Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E964–e973. doi: 10.1073/pnas.1711853115
   PubMed Web of Science ®Google Scholar
• Achkar JM, Cortes L, Croteau P, et al. Host protein biomarkers identify active tuberculosis in HIV uninfected and Co-infected individuals. EBioMedicine. 2015 Sep;2(9):1160–1168.
   PubMed Web of Science ®Google Scholar
• Bark CM, Manceur AM, Malone LL, et al. Identification of host proteins predictive of early stage mycobacterium tuberculosis infection. EBioMedicine. 2017 Jul;21:150–157.
   PubMed Web of Science ®Google Scholar
• Morris TC, Hoggart CJ, Chegou NN, et al. Evaluation of host serum protein biomarkers of tuberculosis in sub-saharan Africa. Front Immunol. 2021;12:639174. doi: 10.3389/fimmu.2021.639174
   PubMed Web of Science ®Google Scholar
• Zak DE, Penn-Nicholson A, Scriba TJ, et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet. 2016 Jun 4;387(10035):2312–2322. doi: 10.1016/S0140-6736(15)01316-1
   PubMed Web of Science ®Google Scholar
• Warsinske HC, Rao AM, Moreira FMF, et al. Assessment of validity of a blood-based 3-gene signature score for progression and diagnosis of tuberculosis, disease severity, and treatment response. JAMA Netw Open. 2018 Oct 5;1(6):e183779. doi: 10.1001/jamanetworkopen.2018.3779
   PubMed Web of Science ®Google Scholar
• Penn-Nicholson A, Hraha T, Thompson EG, et al. Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study. PLOS Med. 2019 Apr;16(4):e1002781.
   PubMed Web of Science ®Google Scholar
• MacPherson P, Webb EL, Lalloo DG, et al. Design and protocol for a pragmatic randomised study to optimise screening, prevention and care for tuberculosis and HIV in Malawi (PROSPECT study). Wellcome Open Res. 2018;3:3. doi: 10.12688/wellcomeopenres.14598.3
   PubMedGoogle Scholar
• Long R, Lau A, Barrie J, et al. Limitations of chest radiography in diagnosing subclinical pulmonary tuberculosis in Canada. Mayo Clin Proc Innov Qual Outcomes. 2023 Jun;7(3):165–170.
   PubMedGoogle Scholar
• Tang P, Liang E, Zhang X, et al. Prevalence and risk factors of subclinical tuberculosis in a low-incidence setting in China. Front Microbiol. 2022;12:4056. doi: 10.3389/fmicb.2021.731532
   Web of Science ®Google Scholar
• Patterson B, Wood R. Is cough really necessary for TB transmission? Tuberculosis. 2019;117:31–35. doi: 10.1016/j.tube.2019.05.003
   PubMed Web of Science ®Google Scholar
• Behr M, Warren S, Salamon H, et al. Transmission of mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet. 1999;353(9151):444–449. doi: 10.1016/S0140-6736(98)03406-0
   PubMed Web of Science ®Google Scholar
• Jiménez-Corona ME, García-García L, DeRiemer K, et al. Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area. Thorax. 2006 Apr;61(4):348–353.
   PubMed Web of Science ®Google Scholar
• Coleman M, Martinez L, Theron G, et al. Mycobacterium tuberculosis transmission in high-incidence settings—new paradigms and insights. Pathogens. 2022 Oct 25;11(11):1228. doi: 10.3390/pathogens11111228
   PubMed Web of Science ®Google Scholar
• Vaezipour N, Fritschi N, Brasier N, et al. Towards accurate point-of-care tests for tuberculosis in children. Pathogens. 2022 Mar 8;11(3):327. doi: 10.3390/pathogens11030327
   PubMed Web of Science ®Google Scholar
• Fritschi N, Wind A, Hammer J, et al. Subclinical tuberculosis in children: diagnostic strategies for identification reported in a 6-year national prospective surveillance study. Clin Infect Dis. 2022 Mar 1;74(4):678–684. doi: 10.1093/cid/ciab708
   PubMed Web of Science ®Google Scholar
• Unterweger M, Götzinger F, Bogyi M, et al. Childhood tuberculosis in Vienna between 2010 and 2016. Wien Klin Wochenschr. 2019 Aug;131(15–16):356–361.
   PubMed Web of Science ®Google Scholar
• Ziemele B, Ranka R, Ozere I. Pediatric and adolescent tuberculosis in Latvia, 2011-2014: case detection, diagnosis and treatment. Int J Tuberc Lung Dis. 2017 Jun 1;21(6):637–645. doi: 10.5588/ijtld.16.0270
   PubMed Web of Science ®Google Scholar
• Dorjee K, Topgyal S, Dorjee C, et al. High prevalence of active and latent tuberculosis in children and adolescents in Tibetan schools in India: the zero TB kids initiative in Tibetan refugee children. Clin Infect Dis. 2019 Aug 16;69(5):760–768. doi: 10.1093/cid/ciy987
   PubMed Web of Science ®Google Scholar
• Laniado-Laborín R. Clinical challenges in the era of multiple and extensively drug-resistant tuberculosis. Rev Panam Salud Publica. 2017;41:e167. doi: 10.26633/RPSP.2017.167
   PubMed Web of Science ®Google Scholar
• Naidoo K, Moodley MC, Hassan-Moosa R, et al. Recurrent subclinical tuberculosis among antiretroviral therapy–accessing participants: incidence, clinical course, and outcomes. Clinl Infect Dis. 2022;75(9):1628–1636. doi: 10.1093/cid/ciac185
   PubMed Web of Science ®Google Scholar
• Kendall EA, Fofana MO, Dowdy DW. Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. Lancet Respir Med. 2015 Dec;3(12):963–972. doi: 10.1016/S2213-2600(15)00458-0
   PubMed Web of Science ®Google Scholar
• Nathavitharana RR, Garcia-Basteiro AL, Ruhwald M, et al. Reimagining the status quo: how close are we to rapid sputum-free tuberculosis diagnostics for all? EBioMedicine. 2022 Apr;78:103939.
   PubMed Web of Science ®Google Scholar